Sarah, a 42-year-old school teacher from Austin, had struggled with obesity after her second pregnancy. With a BMI of 38, she battled joint pain and prediabetes. Despite trying numerous diets and exercise plans, she couldn’t maintain lasting weight loss. Her endocrinologist suggested incorporating semaglutide as part of a comprehensive weight-management plan.
Sarah appreciated how semaglutide helped curb her cravings for sweets, which had been one of the biggest obstacles in her past attempts to lose weight. Alongside the therapy, she worked with a dietitian to develop a sustainable meal plan and began swimming three times a week.
Later, under medical supervision, Sarah transitioned to tirzepatide, which provided even stronger appetite control and enhanced her progress. Over 18 months, she shed 80 pounds, dropping her BMI into a healthy range. Her prediabetes resolved, her joint pain improved, and she regained confidence in her appearance.
“I finally feel like I’m in control,” she shares. Today, Sarah is a vocal advocate for using modern therapies like semaglutide and tirzepatide to support people on their weight-loss journeys.
